{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:36:17Z","timestamp":1771068977672,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.neuroscience.2005.03.004","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T11:45:15Z","timestamp":1115898315000},"page":"701-713","source":"Crossref","is-referenced-by-count":65,"title":["Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue"],"prefix":"10.1016","volume":"133","author":[{"given":"R.H.","family":"Andres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.W.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Schlattner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"P\u00e9rez-Bouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.W.","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Wallimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.R.","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2005.03.004_bib1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000069043","article-title":"Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia","volume":"24","author":"Adcock","year":"2002","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-0173(00)00038-2","article-title":"CNS energy metabolism as related to function","volume":"34","author":"Ames","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington\u2019s disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1471-4159.2001.00188.x","article-title":"Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation","volume":"77","author":"Andreassen","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00415-005-0595-4","article-title":"Creatine supplementation lowers brain glutamate levels in Huntington\u2019s disease","volume":"252","author":"Bender","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib6","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1523\/JNEUROSCI.22-07-02637.2002","article-title":"Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons","volume":"22","author":"Bilsland","year":"2002","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2005.03.004_bib7","doi-asserted-by":"crossref","first-page":"SI29","DOI":"10.1016\/S0140-6736(99)90229-5","article-title":"Neural transplantation for neurodegenerative disorders","volume":"353","author":"Borlongan","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(00)00269-2","article-title":"Endogenous synthesis and transport of creatine in the rat brain","volume":"86","author":"Braissant","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/biof.5520080311","article-title":"The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition","volume":"8","author":"Brdiczka","year":"1998","journal-title":"Biofactors"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib11","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1046\/j.1471-4159.2000.0741968.x","article-title":"Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons","volume":"74","author":"Brewer","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1471-4159.2001.00052.x","article-title":"On the mechanisms of neuroprotection by creatine and phosphocreatine","volume":"76","author":"Brustovetsky","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/cne.903630305","article-title":"Expression of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in the fetal rat brain","volume":"363","author":"Chen","year":"1995","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0006-8993(94)91857-0","article-title":"NT-3 and BDNF protect CNS neurons against metabolic\/excitotoxic insults","volume":"640","author":"Cheng","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E","article-title":"Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death","volume":"57","author":"Choi","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib16","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/jcbfm.1994.140","article-title":"Age-related changes in swine brain creatine kinase-catalyzed 31P exchange measured in vivo using 31P NMR magnetization transfer","volume":"14","author":"Corbett","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib17","first-page":"R698","article-title":"Increase of total creatine in human brain after oral supplementation of creatine-monohydrate","volume":"277","author":"Dechent","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib18","first-page":"195","article-title":"Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine","volume":"79","author":"Decker","year":"1993","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib19","doi-asserted-by":"crossref","first-page":"17760","DOI":"10.1074\/jbc.M208705200","article-title":"Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation","volume":"278","author":"Dolder","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1471-4159.1988.tb02930.x","article-title":"Energy metabolism and quantal acetylcholine release","volume":"50","author":"Dunant","year":"1988","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib21","series-title":"Neural transplantation, a practical approach","first-page":"1","article-title":"Staging and dissection of rat embryos","author":"Dunnett","year":"1992"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00241123","article-title":"Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon","volume":"106","author":"Fawcett","year":"1995","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib23","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington\u2019s disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.neuroscience.2005.03.004_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease","volume":"344","author":"Freed","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.neuroscience.2005.03.004_bib25","first-page":"III44","article-title":"Do patients with Parkinson\u2019s disease benefit from embryonic dopamine cell transplantation?","volume":"250","author":"Freed","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity","volume":"50","author":"Glinka","year":"1997","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.410440207","article-title":"Mitochondrial DNA transmission of the mitochondrial defect in Parkinson\u2019s disease","volume":"44","author":"Gu","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-510X(98)00095-1","article-title":"Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases","volume":"158","author":"Gu","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib29","doi-asserted-by":"crossref","first-page":"C697","DOI":"10.1152\/ajpcell.1997.272.2.C697","article-title":"Metabolic support of Na+ pump in apically permeabilized A6 kidney cell epithelia","volume":"272","author":"Guerrero","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1006895414925","article-title":"Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle","volume":"184","author":"Guerrero-Ontiveros","year":"1998","journal-title":"Mol Cell Biochem"},{"issue":"Pt 2","key":"10.1016\/j.neuroscience.2005.03.004_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1242\/jcs.106.2.671","article-title":"Brain-type creatine kinase in photoreceptor cell outer segments","volume":"106","author":"Hemmer","year":"1993","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000111342","article-title":"Functional aspects of creatine kinase in brain","volume":"15","author":"Hemmer","year":"1993","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00999723","article-title":"Brain cellular and mitochondrial respiration in media of altered pH","volume":"2","author":"Holtzman","year":"1987","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000111343","article-title":"Functional maturation of creatine kinase in rat brain","volume":"15","author":"Holtzman","year":"1993","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0304-3940(94)90372-7","article-title":"Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson\u2019s disease","volume":"169","author":"Janetzky","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-3806(93)90051-B","article-title":"Profound, reversible energy loss in the hypoxic immature rat brain","volume":"73","author":"Jensen","year":"1993","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0306-4522(01)00017-3","article-title":"Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype","volume":"103","author":"Kaemmerer","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","article-title":"Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis","volume":"5","author":"Klivenyi","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib39","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson\u2019s disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib41","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson\u2019s disease. Second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1005419617371","article-title":"Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death","volume":"31","author":"Lemasters","year":"1999","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib43","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1523\/JNEUROSCI.19-04-01284.1999","article-title":"Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons","volume":"19","author":"Lotharius","year":"1999","journal-title":"J Neurosci"},{"issue":"Pt 2","key":"10.1016\/j.neuroscience.2005.03.004_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/115.2.333","article-title":"Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson\u2019s disease","volume":"115","author":"Mann","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib45","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1471-4159.1991.tb03472.x","article-title":"Creatine kinase activity in postnatal rat brain development and in cultured neurons, astrocytes, and oligodendrocytes","volume":"56","author":"Manos","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib46","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/1097-4547(20001215)62:6<814::AID-JNR8>3.0.CO;2-F","article-title":"Metabolic effects of 1-methyl-4-phenylpyridinium (MPP(+)) in primary neuron cultures","volume":"62","author":"Marini","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/exnr.1999.7049","article-title":"Creatine and cyclocreatine attenuate MPTP neurotoxicity","volume":"157","author":"Matthews","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1523\/JNEUROSCI.18-01-00156.1998","article-title":"Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington\u2019s disease","volume":"18","author":"Matthews","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.1999.tb07824.x","article-title":"Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"893","author":"Mattson","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(02)03695-8","article-title":"D-(+)-glucose rescue against 1-methyl-4-phenylpyridinium toxicity through anaerobic glycolysis in neuroblastoma cells","volume":"962","author":"Mazzio","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0006-2952(98)00142-7","article-title":"Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson\u2019s disease","volume":"56","author":"McNaught","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1099-1492(199908)12:5<309::AID-NBM572>3.0.CO;2-Y","article-title":"Proton MRS of oral creatine supplementation in rats. Cerebral metabolite concentrations and ischemic challenge","volume":"12","author":"Michaelis","year":"1999","journal-title":"NMR Biomed"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib53","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-4159.1990.tb01935.x","article-title":"Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture","volume":"54","author":"Michel","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib54","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jnr.490260405","article-title":"Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture","volume":"26","author":"Michel","year":"1990","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0925-4439(95)00038-6","article-title":"Role of mitochondria in the etiology and pathogenesis of Parkinson\u2019s disease","volume":"1271","author":"Mizuno","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib56","first-page":"165","article-title":"Cloning, pharmacological characterization, and genomic localization of the human creatine transporter","volume":"2","author":"Nash","year":"1994","journal-title":"Receptors Channels"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib57","doi-asserted-by":"crossref","first-page":"C205","DOI":"10.1152\/ajpcell.1983.244.3.C205","article-title":"Developmental changes of creatine kinase metabolism in rat brain","volume":"244","author":"Norwood","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib58","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(97)01045-4","article-title":"The role of creatine kinase in inhibition of mitochondrial permeability transition","volume":"414","author":"O\u2019Gorman","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1749-6632.2000.tb06380.x","article-title":"Linear relation between cerebral phosphocreatine concentration and memory capacities during permanent brain vessel occlusions in rats","volume":"903","author":"Plaschke","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib60","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1159\/000111450","article-title":"Expression of the rat brain creatine transporter in situ and in transfected HeLa cells","volume":"18","author":"Saltarelli","year":"1996","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib61","doi-asserted-by":"crossref","first-page":"13166","DOI":"10.1016\/S0021-9258(19)38633-8","article-title":"Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function","volume":"268","author":"Sauter","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib62","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib63","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/exnr.1999.7066","article-title":"Excitotoxicity plays a role in the death of tyrosine hydroxylase- immunopositive nigral neurons cultured in serum-free medium","volume":"157","author":"Schierle","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib64","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.0022-202x.2001.01697.x","article-title":"Creatine kinase and creatine transporter in normal, wounded, and diseased skin","volume":"118","author":"Schlattner","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib65","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/00001756-200006260-00007","article-title":"Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats","volume":"11","author":"Shear","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib66","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1046\/j.1471-4159.1997.68031221.x","article-title":"Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson\u2019s disease","volume":"68","author":"Sheehan","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib67","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1212\/WNL.54.3.703","article-title":"Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson\u2019s disease","volume":"54","author":"Simon","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF00307817","article-title":"Tissue- and cell-specific distribution of creatine kinase B","volume":"280","author":"Sistermans","year":"1995","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-0270(94)90160-0","article-title":"Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon","volume":"54","author":"Spenger","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1460-9568.1995.tb01058.x","article-title":"Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra","volume":"7","author":"Studer","year":"1995","journal-title":"Eur J Neurosci"},{"issue":"5","key":"10.1016\/j.neuroscience.2005.03.004_bib71","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/1531-8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W","article-title":"Dietary supplement creatine protects against traumatic brain injury","volume":"48","author":"Sullivan","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib72","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0963-6897(97)00034-1","article-title":"The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells","volume":"6","author":"Thajeb","year":"1997","journal-title":"Cell Transplant"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib73","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0361-9230(99)00016-7","article-title":"Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia","volume":"48","author":"Toner","year":"1999","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/biof.5520080310","article-title":"Some new aspects of creatine kinase (CK)","volume":"8","author":"Wallimann","year":"1998","journal-title":"Biofactors"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01267955","article-title":"Creatine kinase in non-muscle tissues and cells","volume":"133\u2013134","author":"Wallimann","year":"1994","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib76","first-page":"159","article-title":"Subcellular compartmentation of creatine kinase isoenzymes, regulation of CK and octameric structure of mitochondrial CK","volume":"315","author":"Wallimann","year":"1989","journal-title":"Prog Clin Biol Res"},{"issue":"Pt 1","key":"10.1016\/j.neuroscience.2005.03.004_bib77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj2810021","article-title":"Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands","volume":"281","author":"Wallimann","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib78","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1471-4159.1981.tb06337.x","article-title":"Cerebral synaptic transmission during anoxia is protected by creatine","volume":"37","author":"Whittingham","year":"1981","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib79","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/j.1460-9568.1994.tb00559.x","article-title":"Neurotrophin-4\/5 promotes survival and differentiation of rat striatal neurons developing in culture","volume":"6","author":"Widmer","year":"1994","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/exnr.2000.7418","article-title":"Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons","volume":"164","author":"Widmer","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib81","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1203\/00006450-199801000-00002","article-title":"Creatine protects the central respiratory network of mammals under anoxic conditions","volume":"43","author":"Wilken","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib82","doi-asserted-by":"crossref","first-page":"F224","DOI":"10.1136\/fn.82.3.F224","article-title":"Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation","volume":"82","author":"Wilken","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tins.2004.12.006","article-title":"Cell transplantation in Parkinson\u2019s disease","volume":"28","author":"Winkler","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1471-4159.1979.tb11708.x","article-title":"Formation of a supplemental long time-constant reservoir of high energy phosphate by brain in vivo and in vitro and its reversible depletion by potassium depolarization","volume":"33","author":"Woznicki","year":"1979","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib85","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1471-4159.1988.tb03054.x","article-title":"Utilization of the synthetic phosphagen cyclocreatine phosphate by a simple brain model during stimulation by neuroexcitatory amino acids","volume":"50","author":"Woznicki","year":"1988","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib86","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib87","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1006\/bbrc.1998.9044","article-title":"Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures","volume":"248","author":"Zhang","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2005.03.004_bib88","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1523\/JNEUROSCI.1278-04.2004","article-title":"Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice","volume":"24","author":"Zhu","year":"2004","journal-title":"J Neurosci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452205002861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452205002861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T22:13:40Z","timestamp":1625955220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452205002861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0306452205002861"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2005.03.004","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}